Treatment of acute promyelocytic leukemia with arsenic trioxide.
Conrad
M E
ME
D000970:Antineoplastic Agents / Q000266:history* / Q000627:therapeutic use; D001151:Arsenic / Q000266:history* / Q000627:therapeutic use; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use; D049669:History, 16th Century; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000266:history*; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy; D010087:Oxides / Q000627:therapeutic use; D012074:Remission Induction
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D001151:Arsenic; D000077237:Arsenic Trioxide